A phase II study of bevacizumab in combination with vinorelbine in stage IV breast cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 17 Jan 2013 Biomarkers information updated
- 12 May 2009 Lead trial investigator(Burstein HJ) identified as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.